เกจวัดแรงดันแก๊ส has entered into a definitive settlement to amass Malema Engineering Corp, a US designer and producer of high-precision, mission-critical flow-measurement and management devices for the biopharmaceutical, semiconductor and industrial sectors.
Image: dizain/Adobe Stock.
Malema’s products will broaden Dover’s biopharma single-use production offering, which already includes Quattroflow pumps, CPC connectors, and em-tec flowmeters.
Based in Boca Raton, Florida, and with facilities in San Jose, California, Singapore, South Korea and India, Malema expects to generate approximately US$40 million–45 million in revenue through the full yr 2022.
When the deal closes, Malema will become part of the PSG enterprise unit inside Dover’s Pumps & Process Solutions phase.
“We see an amazing long-term growth opportunity within the bioprocessing trade driven by a robust and growing pipeline of effective novel biologic drugs, biosimilars, protein therapies, non-COVID mRNA vaccines, as nicely as budding cell & gene therapies,” says PSG’s president Karl Buscher. “Additionally, the rising adoption of extra efficient single-use production processes helps a sturdy outlook for our offerings of single-use elements to end-customers. We consider that pairing Malema’s expertise with our current portfolio of single-use pumps for biopharma processing will greatly improve the accuracy and value proposition of our solutions to our prospects.”
“We are methodically constructing out our biopharma platform through proactive capacity additions, new product improvement, and opportunistic acquisitions of highly-attractive niche element technologies,” said Richard Tobin, president and CEO of Dover. “Malema represents a strategic and highly-complementary flow-control and sensing know-how and additional strengthens our sensor portfolio with new proprietary technology. In addition to enticing biopharma applications, we expect robust development in the semiconductor house on the capability growth and re-shoring tailwinds.”
Share